BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Neozyme International, Inc. (ILDO) Announces Large Order For NONTOX From Australian Agent


10/19/2005 5:10:07 PM

COSTA MESA, Calif., Feb. 23 /PRNewswire/ -- Neozyme International, Inc. (Neozyme), a subsidiary of International Daleco Corporation , has received a NONTOX order from its Australian agent. The customer, a major real estate development company, has several, on-site hydrocarbon remediation compliance orders to resolve before construction can begin. Where time of cleanup is financially important, Neozyme's patented NONTOX bioorganic catalyst has proven to accelerate, at an incredible rate, the biological breakdown of hydrocarbon contamination in both soil and water.

A controlled study for the U.S. Air Force, completed in 1997, by a major U.S. engineering company, Metcalf & Eddy, featured the use of NONTOX at a hydrocarbon remediation site on a U.S. base. Concentrations of soluble petroleum were reduced by 50% during a very convincing two-week trial period.

Neozyme manufactures and sells its patented line of bioorganic catalytic formulations for numerous markets including, but not limited to, municipal wastewater treatment, commercial/industrial, hydrocarbon remediation, industrial metal cleaning and agriculture. All Neozyme products are non-toxic, 100% biodegradable and can be safely used around humans, animals, marine life, vegetation and the environment. No special clothing or handling apparatus is required. For more information, please visit http://www.neozyme.com/.

This News Release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based largely on the Company's expectations of forecasts of future events, can be affected by inaccurate assumptions and are subject to various risks and known and unknown uncertainties, a number of which are beyond the Company's control. Therefore, actual results could differ materially from the forward-looking statements herein.

International Daleco Corporation

CONTACT: Parker Dale, Chairman of International Daleco Corporation,+1-949-515-1301, fax, +1-949-515-1314, intldaleco@aol.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES